damnacanthal has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 1 studies
damnacanthal: structure given in first source; isolated from the stem bark and roots of Morinda lucida; a selective inhibitor of p56(lck) tyrosine kinase activity
Excerpt | Relevance | Reference |
---|---|---|
"Therefore, we report that damnacanthal and nordamnacanthal exhibit anticancer properties by inducing apoptosis and necrosis in CEM-SS cells, and they have potential as a drug for the treatment of T-lymphoblastic leukemia." | 4.12 | Ultrastructural and Morphological Effects in T-Lymphoblastic Leukemia CEM-SS Cells Following Treatment with Nordamnacanthal and Damnacanthal from Roots of ( Abdul Rahim, R; Gopalsamy, B; Haji Lajis, N; Latifah, SY; Manaf Ali, A, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Latifah, SY | 1 |
Gopalsamy, B | 1 |
Abdul Rahim, R | 1 |
Manaf Ali, A | 1 |
Haji Lajis, N | 1 |
1 other study available for damnacanthal and Leukemia, Lymphoblastic, Acute, T Cell
Article | Year |
---|---|
Ultrastructural and Morphological Effects in T-Lymphoblastic Leukemia CEM-SS Cells Following Treatment with Nordamnacanthal and Damnacanthal from Roots of
Topics: Aldehydes; Anthraquinones; Apoptosis; Humans; Leukemia, T-Cell; Morinda; Necrosis; Precursor T-Cell | 2022 |